269 related articles for article (PubMed ID: 22208561)
21. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.
Fischer M; You M; Matsumoto M; Crabb DW
J Biol Chem; 2003 Jul; 278(30):27997-8004. PubMed ID: 12791698
[TBL] [Abstract][Full Text] [Related]
22. Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice.
Bakhautdin B; Das D; Mandal P; Roychowdhury S; Danner J; Bush K; Pollard K; Kaspar JW; Li W; Salomon RG; McMullen MR; Nagy LE
J Hepatol; 2014 Nov; 61(5):1029-37. PubMed ID: 24946281
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
Crabb DW; Galli A; Fischer M; You M
Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
[TBL] [Abstract][Full Text] [Related]
24. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.
Lee JH; Banerjee A; Ueno Y; Ramaiah SK
Toxicol Sci; 2008 Nov; 106(1):290-9. PubMed ID: 18703563
[TBL] [Abstract][Full Text] [Related]
25. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
26. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
27. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.
Ki SH; Park O; Zheng M; Morales-Ibanez O; Kolls JK; Bataller R; Gao B
Hepatology; 2010 Oct; 52(4):1291-300. PubMed ID: 20842630
[TBL] [Abstract][Full Text] [Related]
29. PPARα is one of the key targets for dendrobine to improve hepatic steatosis in NAFLD.
Xu Y; Wang M; Luo Y; Liu H; Ling H; He Y; Lu Y
J Ethnopharmacol; 2024 Apr; 323():117684. PubMed ID: 38171466
[TBL] [Abstract][Full Text] [Related]
30. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
Xu Y; Denning KL; Lu Y
Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
[TBL] [Abstract][Full Text] [Related]
31. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice.
Ernst MC; Sinal CJ; Pollak PT
Pharmacol Res; 2010 Nov; 62(5):408-15. PubMed ID: 20654716
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway.
Jiao M; Ren F; Zhou L; Zhang X; Zhang L; Wen T; Wei L; Wang X; Shi H; Bai L; Zhang X; Zheng S; Zhang J; Chen Y; Han Y; Zhao C; Duan Z
Cell Death Dis; 2014 Aug; 5(8):e1397. PubMed ID: 25165883
[TBL] [Abstract][Full Text] [Related]
33. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
[TBL] [Abstract][Full Text] [Related]
34. Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis.
Li TH; Yang YY; Huang CC; Liu CW; Tsai HC; Lin MW; Tsai CY; Huang SF; Wang YW; Lee TY; Huang YH; Hou MC; Lin HC
Clin Sci (Lond); 2019 Feb; 133(3):531-544. PubMed ID: 30602573
[No Abstract] [Full Text] [Related]
35. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
36. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
[TBL] [Abstract][Full Text] [Related]
37. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
39. Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease.
Meng FG; Zhang XN; Liu SX; Wang YR; Zeng T
Chem Biol Interact; 2020 Aug; 327():109176. PubMed ID: 32534989
[TBL] [Abstract][Full Text] [Related]
40. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
